The Food and Drug Administration has published a notice requesting public comment as it conducts a comprehensive review of its regulations.
The review follows an executive order President Obama issued in January compelling government agencies to improve their regulatory processes. The Department of Health and Human Services, under which FDA operates, recently issued a separate notice for comment, available here.
The goal of the FDA review, according to its notice published April 27 in the Federal Register, is to ensure the agency is more effective and less burdensome in achieving its regulatory objectives. "FDA is requesting comment and supporting data on which, if any, of its existing rules are outmoded, ineffective, insufficient, or excessively burdensome and thus may be good candidates to be modified, streamlined, expanded or repealed."
The FDA notice is available here.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access